Bermejo, M.; Meulman, J.; Davanço, M.G.; Carvalho, P.d.O.; Gonzalez-Alvarez, I.; Campos, D.R.
In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium. Pharmaceutics 2020, 12, 558.
https://doi.org/10.3390/pharmaceutics12060558
AMA Style
Bermejo M, Meulman J, Davanço MG, Carvalho PdO, Gonzalez-Alvarez I, Campos DR.
In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium. Pharmaceutics. 2020; 12(6):558.
https://doi.org/10.3390/pharmaceutics12060558
Chicago/Turabian Style
Bermejo, Marival, Jessica Meulman, Marcelo Gomes Davanço, Patricia de Oliveira Carvalho, Isabel Gonzalez-Alvarez, and Daniel Rossi Campos.
2020. "In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium" Pharmaceutics 12, no. 6: 558.
https://doi.org/10.3390/pharmaceutics12060558
APA Style
Bermejo, M., Meulman, J., Davanço, M. G., Carvalho, P. d. O., Gonzalez-Alvarez, I., & Campos, D. R.
(2020). In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium. Pharmaceutics, 12(6), 558.
https://doi.org/10.3390/pharmaceutics12060558
